Are you a Health Professional? Jump over to the doctors only platform. Click Here

Blackmores Flexagil Pain Relief Cream

Print Friendly, PDF & Email

Generic Name: Symphytum officinale (comfrey) 350 mg/g
Product Name: Blackmores Flexagil Pain Relief Cream

Indication of Blackmores Flexagil Pain Relief Cream

Blackmores Flexagil Pain Relief Cream is indicated for:

  • Relieving the pain and swelling of painful joints;
  • Relieving the symptoms of osteoarthritis of the knee;
  • Relieving acute upper and lower back pain;
  • Relieving pain, inflammation, swelling and impaired movement in sports injury including muscle pain;
  • Treating ankle sprains including the relief of pain, tenderness, swelling and impaired mobility;
  • Relieving the pain of soft tissue injury and inflammation e.g. tennis elbow.

Action of Blackmores Flexagil Pain Relief Cream

Symphytum officinale (comfrey) is a natural plant-based medication that has traditionally been applied on the skin for inflammation and pain.

Dose advice of Blackmores Flexagil Pain Relief Cream


Dose information
The manufacturer recommends that the cream is gently rubbed into painful or swollen areas 3 to 4 times daily. Apply only to intact skin (no open wounds). The amount you will need will depend on the size of the painful or swollen area. Typically you will use a thread of cream 2–6 cm in length. Wash your hands after applying the cream, unless they are the area being treated.

Always read the label. If you have any queries about the correct way to use this product, please ask your healthcare professional. Individual results may vary.

Contraindications

Blackmores Flexagil Pain Relief Cream should not be used under certain conditions. Tell your healthcare professional if you have ever had an allergic reaction to:

  • Peanut oil;
  • Any of the ingredients in the cream, including symphytum officinale or comfrey.

 

Precautions

Blackmores Flexagil Pain Relief Cream should not come into contact with the eyes, mucous membranes or open wounds. Application should only be made to intact skin.  Do not use under a dressing that excludes air.

If symptoms persist beyond 7 days (or for 3 weeks for knee osteoarthritis), see your healthcare professional.

Do not use Blackmores Flexagil Pain Relief Cream if the packaging shows signs of tampering or the seal on the tube is broken or missing, or if the product does not look quite right.

If you have any concerns, please speak with your healthcare professional.

Pregnancy

Do not use Blackmores Flexagil Pain Relief Cream if you are pregnant. There is insufficient information about the use of the Cream during pregnancy.

Breastfeeding

Do not use Blackmores Flexagil Pain Relief Cream if you are breastfeeding. There is insufficient information about the use of the Cream during breastfeeding.

Children

Do not use Blackmores Flexagil Pain Relief Cream on children under 12 years.

Schedule of Blackmores Flexagil Pain Relief Cream

Schedule 5. Flexagil is a registered medicine in Australia.1

References

  1. Blackmores Flexagil Pain Relief Cream tube public summary: No. 178341 [online]. Woden, ACT: Therapeutic Goods Administration, eBS Australian Register of Therapeutic Goods Medicines; 13 December 2010 [cited 15 June 2011]. Available from: URL Link
  2. Blackmores Flexagil Pain Relief Cream TGA Approved Package Insert. Blackmores Ltd, NSW: 2011.
  3. Professional Monograph:Comfrey (Symphytum spp.). Natural Standard, 2011 [cited 18 June 2011]. Available from: URL link
  4. Dohil MA et al. Fluocinolone acetonide 0.01% in peanut oil: safety and efficacy data in the treatment of childhood atopic dermatitis in infants as young as 3 months of age. Pediatr Dermatol. 2009;26:262-8. [Abstract]
  5. Ring J et al. Allergy to peanut oil – clinically relevant? J Eur Acad Dermatol Venereol. 2007;21:452-5. [Abstract]
  6. Paller AS et al. Fluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even in patients who are peanut sensitive. J Am Acad Dermatol. 2003;48:569-77. [Abstract]
  7. Yunginger JW et al. Investigation of the allergenicity of a refined peanut oil-containing topical dermatologic agent in persons who are sensitive to peanuts. Cutis. 2001;68:153-5. [Abstract]

Please note that the Product Information including information such as what a product should be used for, how it works, the dosage and relevant side effects is created by the company who makes the product. For registered medicines, the Product Information is carefully validated by the relevant Australian health authority, the Therapeutic Goods Administration (TGA). However, for complementary medicines the Product Information is NOT routinely checked by the TGA. Therefore it is important that you do NOT take any complementary medicine without first speaking with your doctor.

Print Friendly, PDF & Email

Dates

Posted On: 6 December, 2011
Modified On: 17 August, 2017


Created by: myVMC